Illinois Municipal Retirement Fund Acquires 6,835 Shares of Henry Schein, Inc. $HSIC

Illinois Municipal Retirement Fund raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 6.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 112,671 shares of the company’s stock after buying an additional 6,835 shares during the period. Illinois Municipal Retirement Fund owned 0.10% of Henry Schein worth $8,304,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. CYBER HORNET ETFs LLC bought a new stake in Henry Schein in the 2nd quarter valued at $25,000. MUFG Securities EMEA plc acquired a new position in shares of Henry Schein in the second quarter valued at $27,000. Flagship Harbor Advisors LLC bought a new position in shares of Henry Schein in the fourth quarter valued at about $30,000. Federated Hermes Inc. bought a new position in shares of Henry Schein in the fourth quarter valued at about $32,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Henry Schein during the 4th quarter worth about $37,000. 96.62% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, Director William K. Daniel acquired 10,000 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was acquired at an average price of $69.19 per share, with a total value of $691,900.00. Following the completion of the transaction, the director directly owned 20,000 shares of the company’s stock, valued at $1,383,800. This trade represents a 100.00% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.89% of the stock is currently owned by company insiders.

Henry Schein Price Performance

Henry Schein stock opened at $87.82 on Friday. The stock’s fifty day moving average price is $79.50 and its two-hundred day moving average price is $77.72. Henry Schein, Inc. has a one year low of $61.94 and a one year high of $89.34. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.36 and a quick ratio of 0.75. The firm has a market cap of $10.00 billion, a PE ratio of 26.53, a price-to-earnings-growth ratio of 1.70 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. The firm had revenue of $3.37 billion during the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, research analysts expect that Henry Schein, Inc. will post 5.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several research analyst reports. Robert W. Baird set a $97.00 target price on shares of Henry Schein in a report on Wednesday, May 6th. Weiss Ratings restated a “hold (c+)” rating on shares of Henry Schein in a research report on Monday, May 4th. UBS Group reaffirmed a “neutral” rating and issued a $85.00 target price (down from $87.00) on shares of Henry Schein in a research report on Wednesday, May 6th. Mizuho lowered their target price on Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Finally, BTIG Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Thursday, June 11th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $87.64.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.